Search

everythinglearnresearchcommunity

for

Search:↓

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Microneedles in wearables can deliver drugs over time but face challenges in manufacturing and safety.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.